UnitedHealthcare prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
UnitedHealthcare reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers UnitedHealthcare's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at UnitedHealthcare →
- Aflibercept at UnitedHealthcare →
- Apixaban at UnitedHealthcare →
- Atezolizumab at UnitedHealthcare →
- Atogepant at UnitedHealthcare →
- Benralizumab at UnitedHealthcare →
- Bevacizumab at UnitedHealthcare →
- Bictegravir at UnitedHealthcare →
- Buprenorphine at UnitedHealthcare →
- Dapagliflozin at UnitedHealthcare →
- Dulaglutide at UnitedHealthcare →
- Dupilumab at UnitedHealthcare →
- Eculizumab at UnitedHealthcare →
- Elexacaftor Tezacaftor Ivacaftor at UnitedHealthcare →
- Empagliflozin at UnitedHealthcare →
- Erenumab at UnitedHealthcare →
- Evolocumab at UnitedHealthcare →
- Faricimab at UnitedHealthcare →
- Fingolimod at UnitedHealthcare →
- Fremanezumab at UnitedHealthcare →
- Galcanezumab at UnitedHealthcare →
- Glecaprevir Pibrentasvir at UnitedHealthcare →
- Guselkumab at UnitedHealthcare →
- Ibrutinib at UnitedHealthcare →
- Imatinib at UnitedHealthcare →
- Inclisiran at UnitedHealthcare →
- Infliximab at UnitedHealthcare →
- Ixekizumab at UnitedHealthcare →
- Lenalidomide at UnitedHealthcare →
- Liraglutide at UnitedHealthcare →
- Lisdexamfetamine at UnitedHealthcare →
- Mepolizumab at UnitedHealthcare →
- Methylphenidate at UnitedHealthcare →
- Naltrexone at UnitedHealthcare →
- Natalizumab at UnitedHealthcare →
- Nintedanib at UnitedHealthcare →
- Nivolumab at UnitedHealthcare →
- Nusinersen at UnitedHealthcare →
- Ocrelizumab at UnitedHealthcare →
- Ofatumumab at UnitedHealthcare →
- Omalizumab at UnitedHealthcare →
- Ozanimod at UnitedHealthcare →
- Palbociclib at UnitedHealthcare →
- Pembrolizumab at UnitedHealthcare →
- Pirfenidone at UnitedHealthcare →
- Ribociclib at UnitedHealthcare →
- Rimegepant at UnitedHealthcare →
- Risankizumab at UnitedHealthcare →
- Rituximab at UnitedHealthcare →
- Rivaroxaban at UnitedHealthcare →
- Sacubitril Valsartan at UnitedHealthcare →
- Secukinumab at UnitedHealthcare →
- Semaglutide at UnitedHealthcare →
- Sofosbuvir at UnitedHealthcare →
- Tafamidis at UnitedHealthcare →
- Tenofovir Alafenamide at UnitedHealthcare →
- Tezepelumab at UnitedHealthcare →
- Tirzepatide at UnitedHealthcare →
- Tofacitinib at UnitedHealthcare →
- Trastuzumab at UnitedHealthcare →
- Upadacitinib at UnitedHealthcare →
- Ustekinumab at UnitedHealthcare →
Generate a UnitedHealthcare PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to UnitedHealthcare's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com